v3.25.2
Business Segment Information - Summary of EBIDTA by Reporting Segment (Detail) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Segment Reporting Information [Line Items]        
Segment Adjusted EBITDA $ 28,918 $ 27,867 $ 48,407 $ 46,265
Interest expense, net 3,950 4,943 8,456 9,501
Depreciation and amortization 16,871 14,032 51,302 28,894
Share-based compensation expense 7,824 9,959 14,293 18,759
Foreign exchange impact (2,751) 851 (3,795) 2,439
SeaSpine merger-related costs 4,886 5,897 6,016 10,376
Restructuring costs and impairments related to M6 product lines 3,354   15,480  
Strategic investments 353 311 3,867 431
Acquisition-related fair value adjustments (763) 6,117 (1,373) 10,334
Interest and loss on investments (31) 1,813 (31) 1,553
Litigation and investigation costs 4,029 (277) 7,071 1,983
Employee retention credit (2,854)   (2,854)  
Succession charges   5,346   7,556
Loss before income taxes (14,223) (32,359) (66,356) (67,528)
Global Spine [Member]        
Segment Reporting Information [Line Items]        
Segment Adjusted EBITDA 26,433 27,688 45,949 47,578
Global Orthopedics [Member]        
Segment Reporting Information [Line Items]        
Segment Adjusted EBITDA 2,485 179 2,458 (1,313)
Operating Segments [Member]        
Segment Reporting Information [Line Items]        
Segment Adjusted EBITDA 203,121 198,620 396,767 387,228
Non-GAAP cost of sales 55,077 56,427 111,535 112,128
Non-GAAP Sales, general, and administrative 115,159 111,917 225,619 221,876
Non-GAAP Research and development 14,435 17,660 28,910 36,917
Other segment expenses (benefits) 2,470 (134) 6,738 (209)
Non-GAAP Depreciation, amortization, and share-based compensation expense 12,938 15,117 24,442 29,749
Operating Segments [Member] | Global Spine [Member]        
Segment Reporting Information [Line Items]        
Segment Adjusted EBITDA 169,824 168,034 333,660 329,327
Non-GAAP cost of sales 42,811 43,958 87,398 88,812
Non-GAAP Sales, general, and administrative 97,169 92,542 189,708 184,354
Non-GAAP Research and development 11,761 14,118 23,384 30,063
Other segment expenses (benefits) 2,464 (170) 6,907 (137)
Non-GAAP Depreciation, amortization, and share-based compensation expense 10,814 10,102 19,686 21,343
Operating Segments [Member] | Global Orthopedics [Member]        
Segment Reporting Information [Line Items]        
Segment Adjusted EBITDA 33,297 30,586 63,107 57,901
Non-GAAP cost of sales 12,266 12,469 24,137 23,316
Non-GAAP Sales, general, and administrative 17,990 19,375 35,911 37,522
Non-GAAP Research and development 2,674 3,542 5,526 6,854
Other segment expenses (benefits) 6 36 (169) (72)
Non-GAAP Depreciation, amortization, and share-based compensation expense 2,124 5,015 4,756 8,406
Corporate, Non-Segment [Member]        
Segment Reporting Information [Line Items]        
Segment Adjusted EBITDA $ 8,273 $ 11,234 $ 16,331 $ 21,967